Funding steers Cardiovascular Pipeline towards Clinical Entry

Biopharma Corteria, which announced an oversubscribed €65M ($71M) Series A co-led by investment firms OrbiMed (US) and Jeito Capital (EU), will be  using the funding to advance its cardiovascular pipeline into the clinic. Click to read more...

Related Keywords

Philip Janiak ,Thierry Laugel ,Marie Laure Ozoux ,Biopharma Corteria ,Erez Chimovits ,Andreas Wallnoefer ,Philip Jania ,Corteria Pharmaceuticals ,Jeito Capital ,Managing Partner ,Kurma Partners ,Fountain Healthcare Partners ,V Bio Ventures ,Invivo Capital ,Omnes Capital ,Corteria ,Capital ,Heart ,Afeito ,Ardiovascular ,Failure ,Partners ,Orbimed ,Orteriarsquos ,Unmet ,